SCHEMBL21095754

SCHEMBL21095754

O=C(O)C[C@H]1CN2CCC1C2

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SLC6A12 P48065 3/20 0.39
▸ SLC6A11 P48066 3/20 0.39
▸ SLC6A13 Q9NSD5 3/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ CHRNA7 P36544 1/20 0.35
▸ CHRM2 P08172 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21095889 1.00 SLC6A12 (0.39) SLC6A12SLC6A11SLC6A13CHRM1CHRNB2
SCHEMBL21063808 0.90 CHRNA7 (0.41) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
SCHEMBL21063738 0.90 CHRNA7 (0.41) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
SCHEMBL4280104 0.90 CHRNA7 (0.41) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
Hydrochloric Acid SCHEMBL23406281 0.88 SLC6A12 (0.42) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
Hydrochloric Acid SCHEMBL2422058 0.88 SLC6A12 (0.42) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
SCHEMBL29271818 0.88 CHRNA7 (0.40) SLC6A12SLC6A11SLC6A13CHRM1CHRNA4
SCHEMBL9698974 0.82 CHRNA7 (0.39) CHRM1CHRNB2CHRNA4CHRNA7CHRM2
SCHEMBL2416972 0.77 ALDH1A1 (0.38) CHRM1CHRNB2CHRNA4CHRM2MEN1
SCHEMBL4762164 0.77 ALDH1A1 (0.38) CHRM1CHRNB2CHRNA4CHRM2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724188-B1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2023-06-07 — — EP disclosed
WO-2019118528-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2019-06-20 — — WO disclosed
Send feedback